Business
Kneat to Announce 2023 First-Quarter Financial Results May 9, 2023
Kneat to Announce 2023 First-Quarter Financial Results May 9, 2023 Canada NewsWire ...
About this update from Kneat.com, Inc.
[{"type":"text","content":"\n \n \n \n Kneat to Announce 2023 First-Quarter Financial Results May 9, 2023\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n LIMERICK,\n \n Ireland\n \n \n ,\n \n \n May 3, 2023\n \n \n /CNW/ -\n \n kneat.com, inc.\n \n (TSX: KSI) (OTC: KSIOF)\n \n (\"Kneat\" or the \"Company\")\n \n a leader in digitizing and automating validation and quality processes, announced today that the Company will release its financial results for the quarter ended\n \n March 31, 2023\n \n , after TSX market close on\n \n May 9, 2023\n \n .\n \n \n \n \n \n \n \n \n \n \n Eddie Ryan\n \n , Chief Executive Officer and\n \n Hugh Kavanagh\n \n , Chief Financial Officer, will host a conference call and Q&A for sell side analysts via webcast on\n \n May 10, 2023\n \n at\n \n 09:00 ET\n \n (\n \n 14:00 GMT\n \n ).\n \n \n \n Interested parties can register for the live webcast via the following link:\n \n \n \n \n \n Register\n \n \n \n \n The first-quarter financial results will be available from the Financial Information section of the Investors page on the Kneat Solutions website, at:\n \n \n https://kneat.com/investors/\n \n \n \n \n \n About Kneat\n \n \n \n Kneat, a Canadian company with operational headquarters in Limerick,\n \n Ireland\n \n , develops and markets the next-generation Kneat Gx software platform (\"Kneat Gx\"). Multiple business work processes can be configured on the platform, from equipment to computer system validation, through to quality document management. Kneat Gx allows users to author, review, approve, execute testing online, manage any exceptions and post-approve final deliverables in a controlled FDA 21 CFR Part 11/ Eudralex Annex 11 compliant platform. Macro and micro report dashboards enable powerful oversight into all systems, projects, and processes globally. Customer case studies are reporting productivity improvements in excess of 100% and a higher data integrity and compliance standard. For more information visit\n \n \n www.kneat.com\n \n \n .\n \n \n \n \n SOURCE kneat.com, inc.\n \n \n \n \n \n \n View orig...